Can Latin America Outpace U.S. in Trial Speed?

Get ready for bold shifts in MedTech and clinical research—this week’s insights reveal where the future is accelerating fastest: Latin America emerges as a top destination for first-in-human trials FDA launches a new shortcut for ultra-rare disease treatments—what’s the catch? Maze Therapeutics repo

first-in-human · clinical research · FDA · MedTech · rare disease

Get ready for bold shifts in MedTech and clinical research—this week’s insights reveal where the future is accelerating fastest:

Latin America emerges as a top destination for first-in-human trials FDA launches a new shortcut for ultra-rare disease treatments—what’s the catch? Maze Therapeutics reports early promise for kidney and metabolic diseases Quasar expands into Mexico and Ireland, boosting global MedTech capacity

The future of innovation starts now—let’s dive in 👇

← All Global Trial Accelerators editions · Contact bioaccess®